Arsenic trioxide and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Arsenic trioxide (arsenic trioxide), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Thalidomide, and have Acute promyelocytic leukaemia.

The phase IV clinical study analyzes which people have Rashes when taking Arsenic trioxide. It is created by eHealthMe based on reports of 984 people who have side effects when taking Arsenic trioxide from the FDA, and is updated regularly.

What is Arsenic trioxide?

Arsenic trioxide has active ingredients of arsenic trioxide. eHealthMe is studying from 990 Arsenic trioxide users. Check the latest studies of Arsenic trioxide.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 27, 2026

984 people reported to have side effects when taking Arsenic trioxide.
Among them, 12 people (1.22%) have Rashes.

Among these 12 people:

How long have people been on Arsenic trioxide when they have Rashes? *

What is the gender of people who have Rashes when taking Arsenic trioxide? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Rashes when taking Arsenic trioxide? *

What are other drugs people take besides Arsenic trioxide? *

What are other side effects people have besides Rashes? *

Nausea And Vomiting: 5 people, 41.67%
Nausea (feeling of having an urge to vomit): 5 people, 41.67%
Diarrhea: 4 people, 33.33%
Thrombocytopenia (decrease of platelets in blood): 4 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Constipation: 3 people, 25.00%
Itching: 3 people, 25.00%
Dizziness: 3 people, 25.00%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 3 people, 25.00%

What are the existing conditions these people have? *

Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 3 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
Leukaemia (blood or bone marrow cancer): 1 person, 8.33%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 8.33%
Extravasation (leakage of a fluid): 1 person, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Arsenic trioxide and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arsenic trioxide:

Arsenic trioxide (990 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Arsenic trioxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on arsenic trioxide (the active ingredients of Arsenic trioxide) and Arsenic trioxide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.